Recital 5, Regulation (EU) 2026/397

In forcesince 23 Feb 2026

On 15 October 2023, the company Inbiose N.V. (‘the applicant’) submitted an application to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place lacto-N-tetraose (‘LNT’) obtained by microbial fermentation using a genetically modified strain (MG1655) derived from the host strain Escherichia coli (‘E. coli’) K12 (ATCC 700926), on the Union market as a novel food. The applicant requested for the so produced LNT to be used in the same food categories and at the same maximum levels as the currently LNT authorised by Implementing Regulation (EU) 2020/484. Subsequently, on 21 October 2025, the applicant modified the initial request in the application on the use of LNT produced by a derivative strain of Escherichia coli K-12 MG1655 (ATCC 700926) in food supplements to exclude food supplements intended for young children.